Co-activation of NF-?B and MYC renders cancer cells addicted to IL6 for survival and phenotypic stability (2020)
Attributed to:
Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.04.12.038414
Publication URI: http://dx.doi.org/10.1101/2020.04.12.038414
Type: Preprint